Evaluation of Intraarticular Tranexamic Acid to Reduction of Total Blood Loss Following Knee-Arthroplasty

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Blood LossPostoperative Blood LossThromboembolic Complications
Interventions
DRUG

Tranexamic Acid

An anti-fibrinolytic drug injected into the knee joint at the end of surgery, 3 g diluted in 30 ml saline water.

DRUG

Saline water

30 ml of Saline water injected into the knee capsula at the end of surgery.

DRUG

Tranexamic Acid

An anti-fibrinolytic drug injected intravenous at the beginning of surgery for BOTH groups.

Trial Locations (1)

Unknown

Hvidovre University Hospital, Hvidovre

All Listed Sponsors
lead

Hvidovre University Hospital

OTHER

NCT02427412 - Evaluation of Intraarticular Tranexamic Acid to Reduction of Total Blood Loss Following Knee-Arthroplasty | Biotech Hunter | Biotech Hunter